Metformin and B12: a long-term diabetes complication few patients know about

The mechanism: terminal ileum disruption

Vitamin B12 absorption is unusual. Most nutrients absorb relatively passively along the small intestine. B12 absorption is concentrated in the terminal ileum (the last part of the small intestine before it joins the colon), requires intrinsic factor (a protein made by the stomach), and depends on calcium ions to mediate the binding of the B12-intrinsic-factor complex to ileal receptors.

Metformin appears to disrupt this calcium-dependent step. The proposed mechanisms include altered intestinal motility, changes to gut bacterial populations (metformin reshapes the microbiome substantially), interference with calcium availability in the ileal lumen, and possibly direct effects on ileal epithelial transport. The effect is dose- and duration-dependent: low doses for short periods rarely cause measurable deficiency, but standard doses (1500–2000 mg daily) over several years frequently do.

Prevalence and timing

The largest studies (HOME trial follow-up, multiple observational cohorts) suggest 6–30% of long-term metformin users develop biochemical B12 deficiency. The wide range reflects different cohorts and different definitions of deficiency. What's consistent across studies:

• Risk is low in the first year of metformin use
• Risk rises significantly after 4–5 years of continuous use
• Higher daily doses associated with higher risk
• Older patients, vegetarians and people on PPIs (proton pump inhibitors) are at substantially higher risk

For our patient population in Rusholme, where metformin prescribing rates are high in the South Asian community (reflecting earlier-onset type 2 diabetes — see our NICE CG189 guide), and where vegetarian dietary patterns are common, the risk is genuinely elevated.

Symptoms that mimic diabetic peripheral neuropathy

The clinical trap with metformin-induced B12 deficiency is that its symptoms overlap almost completely with diabetic peripheral neuropathy:

• Symmetrical numbness and tingling in feet, sometimes in hands
• Loss of vibration sense and proprioception
• Pins and needles
• Burning pain
• Cognitive slowing or 'brain fog'
• Fatigue

A patient with diabetes for 10 years, on metformin for 8 of those, presenting with new foot numbness is usually labelled as having diabetic peripheral neuropathy — which is so common in long-standing diabetes that it's a reasonable first thought. But a substantial fraction of those patients actually have B12 deficiency contributing to or causing the symptom, and B12 replacement reverses the neurological component if caught early. Diabetic neuropathy doesn't reverse easily; B12 deficiency neuropathy often does.

The clinical lesson: any patient on long-term metformin with new neurological symptoms should have B12 levels checked. NICE CKS now recommends annual B12 testing in long-term metformin users, especially those with symptoms or other risk factors.

Who's most at risk

• Older adults: Reduced gastric acid production, slower bowel transit, often on multiple medications.
• Vegetarian metformin users: Lower dietary B12 baseline means smaller reserves to draw on. South Asian populations both have higher type 2 diabetes rates and higher vegetarian rates — a compounding risk.
• Patients also on PPIs (omeprazole, lansoprazole, esomeprazole): PPIs independently reduce B12 absorption by lowering stomach acid (needed to release B12 from food proteins). Metformin plus PPI is a high-risk combination.
• Bariatric surgery patients: Already reduced absorption capacity.
• Patients with autoimmune gastritis or pernicious anaemia: Pre-existing B12 absorption problems compounded by metformin.

When and how often to test

Reasonable schedule:

• Baseline: Check B12 before starting metformin, or at any point in the first year, to establish a reference.
• After 4–5 years of metformin: Annual B12 testing.
• Any time symptoms develop: New neuropathy, fatigue not otherwise explained, cognitive change — test immediately, regardless of timing.

The standard test is serum B12. If the result is in the grey zone (150–250 pmol/L), active B12 (holotranscobalamin) or methylmalonic acid (MMA) can clarify. See our blood test results guide for context.

Treatment approach

If deficiency is confirmed and metformin is the likely cause:

1. Loading dose: Hydroxocobalamin 1 mg intramuscular three times per week for two weeks (six injections). If neurological symptoms are present, continue every other day until no further improvement.
2. Maintenance: Hydroxocobalamin 1 mg every three months indefinitely, while metformin continues.
3. Alternative for some patients: High-dose oral cyanocobalamin (1000 mcg daily) can maintain B12 levels through passive absorption that bypasses the intrinsic-factor mechanism. Useful for those who prefer not to have ongoing injections. See our hydroxocobalamin vs cyanocobalamin guide for the comparison.

Monitor symptoms and repeat B12 at 3 months and annually thereafter.

Whether to stop metformin (almost always, no)

The question patients sometimes ask: 'Should I just stop the metformin?' The answer is almost always no. Metformin has substantial benefits in type 2 diabetes — glycaemic control, modest weight neutrality or loss, cardiovascular protection, possibly lower cancer incidence. The B12 deficiency it causes is preventable and treatable. Replacing the B12 while continuing the metformin is the standard approach. The only situations where stopping metformin to address B12 might be considered are rare (refractory deficiency despite injections, intolerance of B12 replacement, or alternative diabetes treatment indicated for other reasons).

If you're on metformin and considering switching to Mounjaro or Wegovy for weight management (see Mounjaro vs Wegovy), the GLP-1 may eventually allow metformin dose reduction or discontinuation under specialist supervision — but never abruptly, and never without diabetes-specific input.

How we approach this at Trafford Clinic

For any patient on long-term metformin presenting for B12 testing or symptoms, our standard approach is:

1. Detailed history (duration of metformin, other medications especially PPIs, dietary pattern, symptoms)
2. Serum B12 (and MMA if borderline)
3. FBC to check for macrocytic anaemia (suggests significant deficiency)
4. Confirmed deficiency → hydroxocobalamin loading course → quarterly maintenance

We see B12 patients across Greater Manchester. Our highest-volume site for metformin-and-B12 cases is Rusholme, reflecting the high South Asian diabetic population. We also see patients at Manchester, Old Trafford, Salford, Sale, Altrincham, Chorlton and others.

How to book

Book a B12 test or consultation at traffordclinic.co.uk/vitamin-b12 or call 0161 258 6149. Empire Pharmacy is GPhC-registered (premises 1123966); Haroon Iqbal is an Independent Prescriber (reg. 2051093) with 26 years of pharmacy experience.

Related reading: Hydroxocobalamin vs cyanocobalamin, B12 deficiency symptoms, Reading blood test results.